Consumption and savings of migrants in China – social cohesion perspective

Boosting domestic demand is the task of China’s sustainable economic development, and in particular, China has become an important global consumer market and the savings patterns should be more cohesive and without discriminations. Using data of China Migrants Dynamic Survey, the paper provides new evidence on internal migrants’ savings in China from the perspective of homeownership and family migration. We find that migrants’ savings are 5.25–6.60 percentage points higher than hukou population even when controlling for working, social status, and social insurance coverage which means the migrant will save 1019.88–1647.10 yuan in 2010 price more monthly. Furthermore, we discover housing could partly explain the saving gap, while when we take remittance and family migration into account, the saving rate differences between migrants and hukou population disappears, which means migrants may save to consume when they go back to their hometown with their family members instead of consuming later in the resident cities. The research is carried out taking into account the objectives of social cohesion policy identified at national and international level and their involvement in consumption and saving processes. Our empirical results reveal that homeownership, remittance motive and family migration play important roles in shaping saving behaviour of migrants

Dynamic analysis of torus involute gear including transient elastohydrodynamic effects

The torus involute gear can compensate large axial misalignments and may possess good meshing characteristics without lead correction. In order to study its dynamic characteristics and verify its feasibility of the practical application, a new efficient rigid-elastic coupling dynamic model of multi-tooth is established which includes effects of lubrication oil film and tooth deformations directly in contact simulation of gears. In this model, each tooth is connected with the gearwheel by a rotatable spring-damper element whose stiffness is calculated through analysis of tooth deformation. The normal tooth contact force is determined via Lankarani and Nikravesh model. Variation of contact stiffness and rotatable spring stiffness with contact points are both taken into account. Combined with tooth contact analysis, the computation of friction coefficient is implemented with high efficiency by introducing the average lubrication oil film height. A three-dimension multi-body model of a torus involute gear pair is employed and verified by an impact experiment. The simulated results provide useful information about tooth impacts, dynamic transmission error and lubrication conditions like oil film heights and friction coefficients, and show that this type of gear can work with good meshing characteristics. The contributions in this paper lay theoretical basis for the application of the torus involute gear

Patients with myasthenia gravis with acute onset of dyspnea: predictors of progression to myasthenic crisis and prognosis

Background: Life-threatening myasthenic crisis (MC) occurs in 10–20% of the patients with myasthenia gravis (MG). It is important to identify the predictors of progression to MC and prognosis in the patients with MG with acute exacerbations. Objective: This study aimed to explore the predictors of progression to MC in the patients with MG with acute onset of dyspnea and their short-term and long-term prognosis. Methods: This study is a retrospective cohort study. We collected and analyzed data on all the patients with MG with acute dyspnea over a 10-year period in a single center using the univariate and multivariate analysis. Results: Eighty-six patients with MG were included. In their first acute dyspnea episodes, 36 (41.9%) episodes eventually progressed to MC. A multivariate analysis showed that the early-onset MG (adjusted OR: 3.079, 95% CI 1.052–9.012) and respiratory infection as a trigger (adjusted OR: 3.926, 95% CI 1.141–13.510) were independent risk factors for the progression to MC, while intravenous immunoglobulin (IVIg) treatment prior to the mechanical ventilation (adjusted OR: 0.253, 95% CI 0.087–0.732) was a protective factor. The prognosis did not significantly differ between the patients with and without MC during the MG course, with a total of 45 (52.3%) patients reaching post-intervention status better than minimal manifestations at the last follow-up. Conclusion: When treating the patients with MG with acute dyspnea, the clinicians should be aware of the risk factors of progression to MC, such as early-onset MG and respiratory infection. IVIg is an effective treatment. With proper immunosuppressive therapy, this group of patients had an overall good long-term prognosis

Gastroprotective effect of the root extract of Alpinia officinarum Hance (Zingiberoside) against acute indomethacin-induced gastric injuries in rats: Involvement of H+/K+-ATPase and prostaglandin E receptors

Purpose: To investigate the protective effects of Alpinia officinarum root ethanol extract (AOE) and galangin against acute indomethacin-induced injury on rat gastric mucosaMethods: Sprague-Dawley rats were daily treated with bismuth potassium citrate (0.08 g/kg), AOE at doses of 0.09, 0.18 and 0.36 g/kg; and galangin (0.2 g/kg) for 15 days. Then, gastric injury on rats was induced by intragastric administration of indomethacin (30 mg/kg). Blood flow and thickness of gastric mucosa were determined using neutral red clearance test and Alcian blue staining. The activity of H+/K+-ATPase was assayed using a biochemical kit. Prostaglandin E receptor expressions were assayed by western blotting.Results: High doses of ethanol extract of Alpinia officinarum root significantly inhibited H+/K+-ATPase activity by 8.12 % (p < 0.01), increased gastric mucosal blood flow (p < 0.001), enhanced mucus thickness (p < 0.05), and elevated the activities of prostaglandin E receptors 1 and 4 (p < 0.05).Galangin significantly inhibited H+/K+-ATPase activity by 4.82 % (p < 0.05) and increased gastric mucosal blood flow (p < 0.01).Conclusion: The ethanol extract of Alpinia officinarum root attenuates indomethacin-induced gastric injury by reinforcing gastric mucosal barrier and inhibiting excessive gastric acid secretion. Thus, the extract can be potentially developed for management of gastric injuries. Keywords: Galangin, Gastric mucosal barrier, Gastric acid, Prostaglandin, Indomethaci

Association between clinical factors and result of immune checkpoint inhibitor related myasthenia gravis: a single center experience and systematic review

Background: Neurological immune-related adverse events (nirAEs) are rare toxicities of immune-checkpoint inhibitors (ICI). With the increase use of ICIs, incidence of nirAEs is growing, among which ICI related MG (irMG) is causing high fatality rate. Given the limited evidence, data from a large cohort of patients with irMG is needed to aid in recognition and management of this fatal complication. Objective: This study aimed to summarize clinical characteristics of irMG and explore predictors of irMG clinical outcome. Methods: We summarized our institution's patients who were diagnosed as irMG between Sep 2019 and Oct 2021. We systematically reviewed the literature through Oct 2021 to identify all similar reported patients who met inclusion criteria. As the control group, patients with idiopathic MG were used. We collected data on clinical features, management, and outcomes of both irMG and idioMG cases. Further statistical analysis was conducted. Results: Sixty three irMG patients and 380 idioMG patients were included in the final analysis. For irMG patients, six were from our institution while the rest 57 were from reported cases. The average age of irMG patients is 70.16 years old. Forty three were male. Average time from first ICI injection to symptom onset was 5.500 weeks. Eleven patients had a past history of MG. Higher MGFA classification and higher QMGS rates were observed in irMG patients compared to idioMG patients. For complication, more irMG patients had myositis or myocarditis overlapping compared to idioMG patients. The most commonly used treatment was corticosteroids for both idioMG and irMG. Twenty one patients (35%) with irMG had unfavorable disease outcome. Single variate and multivariate binary logistic regression proved that association with myocarditis, high MGFA classification or QMGS rates at first visit were negatively related to disease outcome in irMG patients. Conclusion: irMG is a life-threatening adverse event. irMG has unique clinical manifestations and clinical outcome compared to idioMG. When suspicious, early evaluation of MGFA classification, QMGS rates and myositis/myocarditis evaluation are recommended

Long-term efficacy of non-steroid immunosuppressive agents in anti-muscle-specific kinase positive myasthenia gravis patients: a prospective study

Background and Purpose: Anti-muscle-specific kinase (MuSK) positive myasthenia gravis (MG) is characterized by a high relapsing rate, thus, choosing the appropriate oral drug regimen is a challenge. This study aimed to evaluate the efficacy of oral immunosuppressants (IS) in preventing relapse in MuSK-MG. Methods: This prospective cohort observational study included patients with MuSK-MG at Peking Union Medical College Hospital between January 1, 2018, and November 15, 2021. The patients were divided into 2 groups: those with (IS+) or without (IS-) non-steroid immunosuppressive agents. The primary outcome was relapsed at follow-up, and the log-rank test was used to compare the proportion of maintenance-free relapse between the groups; hazard ratio (HR) was calculated using the Cox proportional hazards models. Results: Fifty-three of 59 patients with MuSK-MG were included in the cohort, 14 were in the IS+ group, and 39 were in the IS- group. Twenty-four cases in the cohort experienced relapse at least once; the relapse rate was 2/14 (14.3%) in the IS+ group and 22/39 (56.4%) in the IS- group. At the end of follow-up, the proportion of maintenance-free relapse was significantly different between the two groups (log-rank χ2 = 4.94, P = 0.02). Of all the potential confounders, only the use of IS was associated with a reduced risk of relapse. The HR for relapse among patients in the IS+ group was 0.21 (95%CI 0.05–0.58) and was 0.23 (95%CI 0.05–0.93) in a model adjusted for age, sex, relapse history, highest Myasthenia Gravis Foundation of America (MGFA), and accumulated time of steroid therapy. Conclusions: This study provides evidence that oral non-steroid immunosuppressive agents may be beneficial in reducing relapse in patients with MuSK-MG

Iron metabolism patterns in non-anemic patients with myasthenia gravis: a cross-sectional and follow-up study

Background and purpose: Iron metabolism in myasthenia gravis (MG) and factors associated with it are explored by few published studies. Therefore, this study aimed to compare iron metabolism patterns between patients with MG and healthy individuals as well as between the same group of patients before and after immunotherapy, and to identify predictors of iron metabolism disorders in MG. Materials and methods: For this study, 105 patients and healthy individuals were included at baseline, after which paired parametric and non-parametric tests were adopted to compare their iron metabolism patterns, and multivariate binary logistic regression was used to identify predictors of iron metabolism disorders. Patients with MG were then followed up for 12 ± 3 months to explore alterations in their iron metabolism patterns after starting immunotherapy with the help of paired tests. Results: Non-anemic immunotherapy-naive patients with MG had significantly lower serum iron (SI) and transferrin saturation (TS) levels than healthy individuals. Premenopausal female was significantly associated with SI < 65 µg/dL and iron deficiency in these patients. However, iron metabolism parameters did not significantly alter after around 12 months of immunotherapy in patients with MG. Conclusion: Iron inadequacy was present in patients with MG, particularly premenopausal female patients, and it would hardly improve after immunotherapy. Given the significant role of iron in human body, it should be given more attention in patients with MG

The Physical Properties of High-Mass Star-Forming Clumps: A Systematic Comparison of Molecular Tracers

We present observations of HCO+ and H^13CO+, N2H+, HCS+, HCN and HN^13C, SO and ^34SO, CCH, SO_2, and CH_3OH-E towards a sample of 27 high-mass clumps coincident with water maser emission. All transitions are observed with or convolved to nearly identical resolution (30"), allowing for inter-comparison of the clump properties derived from the mapped transitions. We find N2H+ emission is spatially differentiated compared to the dust and the other molecules towards a few very luminous cores (10 of 27) and the N2H+ integrated intensity does not correlate well with dust continuum flux. We calculate the effective excitation density, n_eff, the density required to excite a 1 K line in T_kin=20 K gas for each molecular tracer. The intensity of molecular tracers with larger effective excitation densities (n_eff > 10^5 cm^-3) appear to correlate more strongly with the submillimeter dust continuum intensity. The median sizes of the clumps are anti-correlated with the n_eff of the tracers (which span more than three orders of magnitude). Virial mass is not correlated with n_eff, especially where the lines are optically thick as the linewidths may be broadened significantly by non-virial motions. The median mass surface density and median volume density of the clumps is correlated with n_eff indicating the importance of understanding the excitation conditions of the molecular tracer when deriving the average properties of an ensemble of cores.Comment: 75 pages, 38 figure

3D acoustic wave sparsely activated localization microscopy with phase change contrast agents

Objective The aim of this study is to demonstrate 3-dimensional (3D) acoustic wave sparsely activated localization microscopy (AWSALM) of microvascular flow in vivo using phase change contrast agents (PCCAs). Materials and Methods Three-dimensional AWSALM using acoustically activable PCCAs was evaluated on a crossed tube microflow phantom, the kidney of New Zealand White rabbits, and the brain of C57BL/6J mice through intact skull. A mixture of C3F8 and C4F10 low-boiling-point fluorocarbon gas was used to generate PCCAs with an appropriate activation pressure. A multiplexed 8-MHz matrix array connected to a 256-channel ultrasound research platform was used for transmitting activation and imaging ultrasound pulses and recording echoes. The in vitro and in vivo echo data were subsequently beamformed and processed using a set of customized algorithms for generating 3D super-resolution ultrasound images through localizing and tracking activated contrast agents. Results With 3D AWSALM, the acoustic activation of PCCAs can be controlled both spatially and temporally, enabling contrast on demand and capable of revealing 3D microvascular connectivity. The spatial resolution of the 3D AWSALM images measured using Fourier shell correlation is 64 μm, presenting a 9-time improvement compared with the point spread function and 1.5 times compared with half the wavelength. Compared with the microbubble-based approach, more signals were localized in the microvasculature at similar concentrations while retaining sparsity and longer tracks in larger vessels. Transcranial imaging was demonstrated as a proof of principle of PCCA activation in the mouse brain with 3D AWSALM. Conclusions Three-dimensional AWSALM generates volumetric ultrasound super-resolution microvascular images in vivo with spatiotemporal selectivity and enhanced microvascular penetration